Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Dermatol ; 152(2): 334-41, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15727648

ABSTRACT

BACKGROUND: Atopic dermatitis (AD) is a common inflammatory allergic disease of children. The primary anti-inflammatory therapy is topical steroids. An effective treatment without the topical and systemic adverse effects of corticosteroids would be useful. Topical formulations of sodium cromoglicate have been researched in the past, but without consistent results. We report a trial of a new aqueous skin lotion of sodium cromoglicate (Altoderm) in children with AD. OBJECTIVES: To compare the efficacy, safety and acceptability of Altoderm lotion with a placebo control in the treatment of AD in children. METHODS: A double-blind, controlled study in which children aged 2-12 years with AD were randomized to 12 weeks of treatment with a lotion containing 4% sodium cromoglicate (Altoderm) or the lotion base. To be included subjects had to have a SCORAD score of > or = 25 and < or = 60 at both of two clinic visits 14 days apart. Subjects continued using existing treatment which included emollients and topical steroids. The primary outcome was the change in the SCORAD score. The two groups were compared for the change in the SCORAD score from the second baseline visit to the visit after 12 weeks of treatment using an analysis of variance. Secondary outcome measures included parents' assessment of symptoms, usage of topical steroids recorded on daily diary cards, and final opinions of treatment by parent and clinician. Parents were asked about adverse effects at each clinic visit and the responses recorded. RESULTS: Fifty-eight children were randomized to Altoderm and 56 to placebo and all were included in the intention-to-treat analysis. The mean +/- SD SCORAD scores at baseline were 41.0 +/- 9.0 (Altoderm) and 40.4 +/- 8.73 (placebo). These scores were reduced after 12 weeks by 13.2 (36%) with Altoderm and by 7.6 (20%) with placebo. The difference of 5.6 (95% confidence interval 1.0-10.3) is statistically significant (P = 0.018). Diary card symptoms improved with both treatments but the improvement was greater in the Altoderm-treated patients. Topical steroid usage was reduced in both groups and was larger in the Altoderm-treated patients. The differences were statistically significant for the mean of all symptoms, the overall skin condition and use of topical steroids. Those for itching and sleep loss were not. Treatment-related adverse events were reported in 11 subjects (Altoderm seven, placebo four). Most of these referred to irritation, redness and burning at the site of application. There were four reports of erythema and pruritus (Altoderm three, placebo one), and three reports of application site burning (Altoderm two, placebo one). None was reported as severe or very severe. CONCLUSIONS: These results show a clinically useful benefit of this sodium cromoglicate lotion in children with moderately severe AD.


Subject(s)
Cromolyn Sodium/therapeutic use , Dermatitis, Atopic/drug therapy , Dermatologic Agents/therapeutic use , Administration, Cutaneous , Child , Child, Preschool , Cromolyn Sodium/adverse effects , Dermatitis, Atopic/pathology , Dermatologic Agents/adverse effects , Double-Blind Method , Drug Administration Schedule , Drug Therapy, Combination , Glucocorticoids/administration & dosage , Humans , Male , Patient Satisfaction , Severity of Illness Index , Treatment Outcome
2.
Arch Dis Child Fetal Neonatal Ed ; 89(1): F57-60, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14711858

ABSTRACT

OBJECTIVE: To describe the immune response of preterm infants to a diphtheria/tetanus/three component acellular pertussis (DTaP) vaccine, under an accelerated schedule, and the effects of steroids on this response. To compare responses with those of term infants. DESIGN: Prospective observational study. SETTING: Five Wessex neonatal units; Hertfordshire immunisation clinics. PATIENTS: Infants born at < 32 weeks; term controls. INTERVENTIONS: DTaP-Haemophilus influenzae type b vaccine given at 2, 3, and 4 months. Blood taken to assess antibody responses to vaccines. MAIN OUTCOME MEASURES: IgG geometric mean concentrations (GMC) to vaccines. RESULTS: A total of 130 preterm (mean gestational age 29.1 weeks) and 54 term infants were recruited. After the third immunisation, preterm infants had similar GMCs to controls to diphtheria, tetanus, filamentous haemagglutinin (FHA), and pertactin (PRN), but a significantly lower GMC to pertussis toxin (PT). Responses to tetanus and PRN increased with age at the third immunisation, and those to tetanus, FHA, PRN, and PT increased with gestational age at birth. Response to tetanus correlated negatively with the number of doses of antenatal steroids received. There was no association between responses and postnatal steroids. CONCLUSION: When immunised with a combined acellular pertussis- H influenzae type b vaccine under an accelerated schedule, IgG GMC of preterm infants to PT was reduced. GMCs to tetanus, FHA, PRN, and PT increased with gestational age at birth, and GMCs to tetanus and PRN increased with age at the third immunisation. There is, however, no benefit in delaying immunisation. Anti-tetanus IgG decreased with increasing number of doses of antenatal steroids. There was no effect for postnatal steroids.


Subject(s)
Diphtheria-Tetanus-acellular Pertussis Vaccines/administration & dosage , Infant, Premature/immunology , Age Factors , Bacterial Outer Membrane Proteins/immunology , Birth Weight , Diphtheria Toxin/immunology , Drug Administration Schedule , Enzyme-Linked Immunosorbent Assay/methods , Female , Gestational Age , Haemophilus influenzae type b/immunology , Hemagglutinins/immunology , Humans , Immunoglobulin G/blood , Infant, Newborn , Male , Pertussis Toxin/immunology , Prenatal Care/methods , Prospective Studies , Steroids/therapeutic use , Tetanus Toxin/immunology , Virulence Factors, Bordetella/immunology
3.
Osteoporos Int ; 2(4): 164-7, 1992 Jul.
Article in English | MEDLINE | ID: mdl-1611220

ABSTRACT

Coined in French in the early 1820s as a mere description of a pathological state of the bone, the term 'osteoporosis' made its way into the English medical vocabulary only in the twentieth century. Unlike other medical concepts, which have not been substantially altered by progress in medical research, the definition of osteoporosis has constantly reflected the state of knowledge on the phenomenon itself. Over its 170 years of evolution, this definition has continuously sought to maintain a difficult balance between physiological and clinical criteria. Even at present, while the 1990 Consensus Conference definition (centering mainly on physiological deterioration) merely implies the clinical aspect through the notions of fragility and fracture risk, others advocate restriction of the term to the clinical consequences of osteopenia. How will the concept of osteoporosis develop in the future? This article, which deals with the origin of the term and its successive definitions, is offered as a basis for further discussion on this subject of high topicality.


Subject(s)
Osteoporosis/history , Terminology as Topic , France , History, 18th Century , History, 19th Century , History, 20th Century
4.
Am J Med ; 87(4): 434-6, 1989 Oct.
Article in English | MEDLINE | ID: mdl-2801733

ABSTRACT

The purpose of this report is to show that a number of scientists feel dissatisfied with the rigid structure of the scientific article as a pattern of communication. Through examples taken from specialized medical journals, we follow their way from sporadic literary quotations supporting their own texts to attempted literary creations on scientific and moral issues.


Subject(s)
Science , Writing , Humans , Literature , Physicians
5.
Eur J Radiol ; 4(2): 114-7, 1984 May.
Article in English | MEDLINE | ID: mdl-6734608

ABSTRACT

25 patients with adenocarcinoma of the oesophagogastric junction were evaluated preoperatively with thoracoabdominal computed tomography (CT). Despite limitations mainly in differentiating intramural from early extramural tumour growth and in predicting peritoneal carcinomatosis, CT was useful in determining local and distant spread of the malignancy and in assessing surgical resectability. CT may identify candidates for palliative procedures such as oesophageal intubation, radiation therapy or chemotherapy by demonstrating inoperability thus avoiding unnecessary surgery. CT should be performed routinely in all patients with carcinoma of the oesophagogastric junction.


Subject(s)
Adenocarcinoma/diagnostic imaging , Esophageal Neoplasms/diagnostic imaging , Esophagogastric Junction , Stomach Neoplasms/diagnostic imaging , Adult , Aged , Esophageal Neoplasms/pathology , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Staging , Stomach Neoplasms/pathology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...